Dextenza 0.4 MG insert 10S
Ended Awarded
- Contract number
- SPE2DB25FSTB1
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,882
Award facts
- Contract value 100% obligated
- $10,881.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $10,881.72 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for DEXTENZA 0.4 mg inserts (10 units) on September 4, 2025, with an ultimate completion date of September 25, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. DEXTENZA is a corticosteroid ophthalmic insert used to reduce post-operative inflammation following ocular surgery, and this delivery order represents a specific product pull from the company's broader pharmaceutical supply relationship with the Defense Logistics Agency.
This award is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 through November 2026. The IDC, established under the SPE2DB program, enables the agency to procure a comprehensive range of branded and generic pharmaceutical products, biologics, medical consumables, and devices to support military healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently delivering specialized medical products ranging from contraceptive devices to oncology treatments and vaccines to Department of Defense healthcare sites.
Quick answers
Who was awarded contract SPE2DB25FSTB1?
SPE2DB25FSTB1 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 4, 2025.
How much is contract SPE2DB25FSTB1 worth?
The government has obligated $10,882 on SPE2DB25FSTB1.
Is contract SPE2DB25FSTB1 an order under another contract?
Yes. SPE2DB25FSTB1 is a delivery order under SPE2DB22D9304, an indefinite delivery contract.
Was contract SPE2DB25FSTB1 competed?
The extent of competition for SPE2DB25FSTB1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award